Sumitomo Pharma Investor Relations Material
Latest events
Q1 2026
Sumitomo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sumitomo Pharma Co Ltd
Access all reports
Sumitomo Pharma Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription drugs and medical solutions. The company focuses on therapeutic areas such as psychiatry, neurology, oncology, and infectious diseases. The company is headquartered in Osaka, Japan, and its shares are listed on the Tokyo Stock Exchange (TSE).
Key slides for Sumitomo Pharma Co Ltd
Q4 2025
Sumitomo Pharma Co Ltd
Q3 2025
Sumitomo Pharma Co Ltd
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
4506
Country
🇯🇵 Japan